Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 297

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Microvascular dysfunction in COVID-19: the MYSTIC study

Open access
Rovas, Alexandros, Osiaevi, Irina, Buscher, Konrad, Sackarnd, Jan, Tepasse, Phil-Robin, Fobker, Manfred, Kühn, Joachim, Braune, Stephan, Göbel, Ulrich, Thölking, Gerold, Gröschel, Andreas, Pavenstädt, Hermann, Vink, Hans, Kümpers, Philipp·2021·Angiogenesis

Abstract

Rationale: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. Objectives: To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. Methods: Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (VRBC), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. Measurements and main results: COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of VRBC. Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. Conclusions: Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10456-020-09753-7

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Metadata

Authors
Rovas, A., Osiaevi, I., Buscher, K., Sackarnd, J., Tepasse, P.-R., Fobker, M., Kühn, J., Braune, S., Göbel, U., Thölking, G., Gröschel, A., Pavenstädt, H., Vink, H., & Kümpers, P.
Venue
Angiogenesis
Published
2020-10-14
Volume
24
Issue
1
Pages
145-157
ISSN
  • 0969-6970 (ISSN-L)
  • 1573-7209
OpenAlex
W3093015530
Cited by
297
References
37
FWCI
6.82
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microvascular dysfunction in COVID-19: the MYSTIC study. https://app.cochat.ai/papers/10.1007/s10456-020-09753-7
The paper
Rovas, A., Osiaevi, I., Buscher, K., Sackarnd, J., Tepasse, P.-R., Fobker, M., Kühn, J., Braune, S., Göbel, U., Thölking, G., Gröschel, A., Pavenstädt, H., Vink, H., & Kümpers, P. (2021). Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis. https://doi.org/10.1007/s10456-020-09753-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.